FDA Inspection
Ascent Pharmaceuticals IncAscent Pharmaceuticals Inc – FDA Inspection, Nov 7, 2018
Record Details
This FDA Inspection record concerns Ascent Pharmaceuticals Inc, with an inspection on November 7, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b6df4373-5d5c-4445-88c2-715ab5b7de63
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1074882
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Ascent Pharmaceuticals Inc
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 3, 2025 | Not classified | New York District Office | |
| August 9, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 15, 2022 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 13, 2020 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 27, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Ascent Pharmaceuticals Inc
- FDA Inspection 1261247 - 2025-02-03
- FDA Inspection 1229681 - 2024-08-09
- FDA Inspection 1179615 - 2022-09-15
- FDA Inspection 1132410 - 2020-10-13
- FDA Inspection 1067030 - 2018-07-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.